Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Verrulactones D and E with unprecedented skeletons, new inhibitors of Staphylococcus aureus enoyl-ACP reductase, from Penicillium verruculosum F375.

× No keyword cloud information.

11 in total

Review 1. Inhibiting bacterial fatty acid synthesis.

Authors: Yong-Mei Zhang; Stephen W White; Charles O Rock
Journal: J Biol Chem Date: 2006-04-28 Impact factor: 5.157

2. Triclosan targets lipid synthesis.

Authors: L M McMurry; M Oethinger; S B Levy
Journal: Nature Date: 1998-08-06 Impact factor: 49.962

Review 3. Challenges of antibacterial discovery.

Authors: Lynn L Silver
Journal: Clin Microbiol Rev Date: 2011-01 Impact factor: 26.132

4. From triclosan toward the clinic: discovery of nonbiocidal, potent FabI inhibitors for the treatment of resistant bacteria.

Authors: Vincent Gerusz; Alexis Denis; Fabien Faivre; Yannick Bonvin; Mayalen Oxoby; Sophia Briet; Géraldine LeFralliec; Chrystelle Oliveira; Nicolas Desroy; Cédric Raymond; Laëtitia Peltier; François Moreau; Sonia Escaich; Vanida Vongsouthi; Stéphanie Floquet; Elodie Drocourt; Armelle Walton; Laure Prouvensier; Marc Saccomani; Lionel Durant; Jean-Marie Genevard; Vanessa Sam-Sambo; Coralie Soulama-Mouze
Journal: J Med Chem Date: 2012-10-23 Impact factor: 7.446

5. Verrulactones A and B, new inhibitors of Staphylococcus aureus enoyl-ACP reductase produced by Penicillium verruculosum F375.

Authors: Nyung Kim; Mi-Jin Sohn; Chang-Jin Kim; Ho Jeong Kwon; Won-Gon Kim
Journal: Bioorg Med Chem Lett Date: 2012-02-09 Impact factor: 2.823

6. Verrulactone C with an unprecedented dispiro skeleton, a new inhibitor of Staphylococcus aureus enoyl-ACP reductase, from Penicillium verruculosum F375.

Authors: Nyung Kim; Mi-Jin Sohn; Hiroyuki Koshino; Eun-Hee Kim; Won-Gon Kim
Journal: Bioorg Med Chem Lett Date: 2013-12-04 Impact factor: 2.823

Verrulactones D and E with unprecedented skeletons, new inhibitors of Staphylococcus aureus enoyl-ACP reductase, from Penicillium verruculosum F375.

Review 1. Inhibiting bacterial fatty acid synthesis.

2. Triclosan targets lipid synthesis.

Review 3. Challenges of antibacterial discovery.

4. From triclosan toward the clinic: discovery of nonbiocidal, potent FabI inhibitors for the treatment of resistant bacteria.

5. Verrulactones A and B, new inhibitors of Staphylococcus aureus enoyl-ACP reductase produced by Penicillium verruculosum F375.

6. Verrulactone C with an unprecedented dispiro skeleton, a new inhibitor of Staphylococcus aureus enoyl-ACP reductase, from Penicillium verruculosum F375.

7. The MUT056399 inhibitor of FabI is a new antistaphylococcal compound.

8. Vinaxanthone, a new FabI inhibitor from Penicillium sp.

Review 9. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.

10. Macrolactin S, a new antibacterial agent with FabG-inhibitory activity from Bacillus sp. AT28.